Please use this identifier to cite or link to this item: https://doi.org/10.3390/molecules17044703
Title: Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6- phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives
Authors: Ding, H.
Chen, Z.
Zhang, C.
Xin, T.
Wang, Y.
Song, H.
Jiang, Y.
Chen, Y. 
Xu, Y.
Tan, C.
Keywords: 1-b]thiazoles
Cytotoxic activity
Imidazo[2
Synthesis
Issue Date: Apr-2012
Citation: Ding, H., Chen, Z., Zhang, C., Xin, T., Wang, Y., Song, H., Jiang, Y., Chen, Y., Xu, Y., Tan, C. (2012-04). Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6- phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives. Molecules 17 (4) : 4703-4716. ScholarBank@NUS Repository. https://doi.org/10.3390/molecules17044703
Abstract: A series of novel compounds bearing imidazo[2,1-b]thiazole scaffolds were designed and synthesized based on the optimization of the virtual screening hit compound N-(6-morpholinopyridin-3-yl)-2-(6-phenylimidazo[2,1-b]thiazol-3-yl) acetamide (5a), and tested for their cytotoxicity against human cancer cell lines, including HepG2 and MDA-MB-231. The results indicated that the compound 2-(6-(4-chlorophenyl)imidazo [2,1-b]thiazol-3-yl)-N-(6-(4-(4-methoxybenzyl) piperazin-1-yl)pyridin-3-yl)acetamide (5l), with slightly higher inhibition on VEGFR2 than 5a (5.72% and 3.76% inhibitory rate at 20 μM, respectively), was a potential inhibitor against MDA-MB-231 (IC50 = 1.4 μM) compared with sorafenib (IC50 = 5.2 μM), and showed more selectivity against MDA-MB-231 than HepG2 cell line (IC50 = 22.6 μM). © 2012 by the authors.
Source Title: Molecules
URI: http://scholarbank.nus.edu.sg/handle/10635/106392
ISSN: 14203049
DOI: 10.3390/molecules17044703
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on Aug 11, 2018

WEB OF SCIENCETM
Citations

11
checked on Jul 17, 2018

Page view(s)

19
checked on Mar 11, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.